This randomized clinical trial demonstrated that preoperative administration of low-molecular-weight-heparin (LMWH) is safe and feasible for lung cancer patients preparing to receive minimally invasive surgery.

The authors concluded that among patients who had undergone gynecological laparoscopic surgery, the incidence of postoperative deep vein thrombosis (DVT) was high, and that this incidence can be reduced by targeting high-risk factors.

Duration of thromboprophylaxis following major abdominopelvic cancer-related surgery – an aid to informed clinical decisionmaking.